BLD Form 4: VP & CHRO Exercises Options, Sells All 1,473 Shares
Rhea-AI Filing Summary
Jennifer Shoffner, Vice President & CHRO of TopBuild Corp. (BLD), exercised an employee stock option on 08/22/2025 with an exercise price of $214.58 to acquire 1,473 shares of TopBuild common stock. The reporting table shows the shares were sold in multiple transactions at prices ranging from $440.00 to $440.69 and the reporting person held 0 shares following the transactions. The Form 4 was filed on behalf of the reporting person and signed via attorney-in-fact on 08/25/2025. The filing includes a footnote stating the filer will provide the exact number of shares sold at each price in the stated range upon SEC request.
Positive
- Transparent disclosure: The filing specifies exercise price, number of options exercised, sale price range, and states willingness to supply per-price sale quantities to the SEC.
- Realized gain potential: The shares were sold at prices significantly above the reported exercise price, indicating a substantive per-share spread as disclosed.
Negative
- No retained shares reported: The reporting person holds 0 shares following the transactions, reducing insider ownership disclosed in this filing.
- Sale price detail limited: The filing provides a price range rather than exact quantities at each price, requiring follow-up to obtain full per-price allocation.
Insights
TL;DR: Officer exercised options and sold all 1,473 resulting shares at roughly $440 each, realizing a sizable per-share spread over exercise price.
This Form 4 documents a routine insider exercise-and-sell transaction by a senior executive. The officer exercised options with a $214.58 strike and the underlying shares were sold at prices between $440.00 and $440.69, which implies a material per-share gain versus the strike price on a per-share basis as reported in the filing. The report shows zero shares retained post-transaction, indicating no ongoing direct exposure from these particular shares. The filing is a standard Section 16 disclosure and contains a footnote committing to provide a breakdown of quantities sold at each reported price within the stated range.
TL;DR: The disclosure is timely and complete for a common exercise-and-sale; no outstanding retained shares reported from this transaction.
The Form 4 identifies the reporting person as an officer (Vice President & CHRO) and indicates the transaction code 'M' consistent with exercise/exchange activity. The reporting person disposed of all shares acquired from the option exercise, leaving 0 shares beneficially owned from this grant according to the report. The signature by attorney-in-fact and the footnote committing to provide per-price sale quantities are standard procedural details that preserve disclosure transparency.